middl
east
respiratori
syndrom
mer
viral
respiratori
diseas
caus
de
novo
coronavirusmerscovthat
associ
high
mortal
howev
mechan
merscov
infect
human
remain
unclear
date
effect
vaccin
antibodi
human
immun
treatment
safeti
toler
fulli
human
polyclon
immunoglobulin
g
igg
antibodi
put
therapeut
agent
specif
mer
although
rapid
diagnost
public
health
measur
current
implement
new
case
merscov
infect
still
report
therefor
variou
effect
measur
taken
prevent
seriou
impact
similar
epidem
futur
investig
epidemiolog
pathogenesi
viru
well
develop
effect
therapeut
prophylact
antimerscov
infect
necessari
purpos
detail
inform
merscov
protein
need
review
describ
major
structur
nonstructur
protein
merscov
summar
differ
potenti
strategi
limit
outbreak
merscov
combin
comput
biolog
virolog
acceler
advanc
design
develop
effect
peptid
therapeut
merscov
summari
review
provid
import
inform
progress
elimin
mer
prevent
treatment
coronaviru
cov
envelop
posit
singlestrand
rna
viru
caus
mild
upper
respiratori
infect
human
middl
east
respiratori
syndrom
mer
viral
respiratori
diseas
caus
de
novo
coronavirusmerscov
merscov
origin
isol
arab
patient
die
respiratori
failur
renal
failur
classifi
member
cov
famili
lineag
c
genu
betacoronaviru
april
may
total
global
number
laboratoryconfirm
mer
case
report
world
health
organ
associ
death
fatal
saudi
arabia
asid
merscov
cov
known
infect
human
includ
human
coronaviru
hcov
usual
result
rel
mild
respiratori
diseas
howev
sever
acut
respiratori
syndrom
sar
cov
merscov
highli
pathogen
lead
high
mortal
especi
elderli
immunocompromis
patient
mer
broken
countri
around
world
major
outbreak
occur
saudi
arabia
unit
arab
emir
korea
dromedari
camel
largest
intermedi
host
merscov
bat
consid
anim
sourc
merscov
howev
specif
role
dromedari
transmiss
viru
yet
clear
date
addit
safeti
toler
fulli
human
polyclon
immunoglobulin
g
igg
antibodi
describ
put
therapeut
agent
specif
mer
effect
vaccin
antibodi
report
human
immun
therapi
therefor
differ
intervent
method
need
treat
mer
patient
includ
control
transmiss
review
describ
structur
potenti
function
report
merscov
protein
discuss
respect
intervent
strategi
prevent
viru
transmiss
mani
cov
includ
merscov
larg
rna
genom
kb
least
ten
predict
open
read
frame
orf
orf
structur
protein
arrang
similar
arrang
cov
lineag
c
genu
betacoronaviru
research
target
gene
encod
protein
use
vaccin
diagnost
therapeut
purpos
tabl
like
cov
merscov
carri
gene
encod
accessori
protein
ap
antagon
host
antivir
responsestyp
type
interferon
ifn
responsesand
contribut
virul
pathogenesi
express
alon
cov
ap
appear
interfer
innat
antivir
signal
pathway
spike
protein
merscov
type
transmembran
glycoprotein
express
surfac
envelop
viru
form
spike
viru
bodi
protein
compris
amino
acid
heavili
glycosyl
larg
extracellular
domain
short
cytoplasm
termin
protein
subdivid
import
effect
viru
bind
fusion
entri
subunit
ntermin
domain
ntd
receptorbind
domain
rbd
compris
residu
mersrbd
contain
intern
extern
subdomain
intern
subdomain
rel
conserv
among
cov
wherea
structur
extern
subdomain
cov
vari
greatli
extern
subdomain
mainli
particip
receptor
bind
result
use
differ
receptor
cov
rbd
respons
bind
dipeptidyl
peptidas
iv
also
known
human
interestingli
mersrbd
induc
strong
product
antibodi
vivo
indic
protein
good
immunogen
induct
neutral
antibodi
nab
immunogen
protect
potenti
ntd
studi
recombin
ntermin
domain
rntd
candid
vaccin
mer
two
region
subunit
particip
viral
fusionnam
heptapeptid
repeat
assembl
typic
sixhelix
bundl
also
call
fusion
core
three
chain
side
groov
core
emit
three
spiral
form
central
coil
spiral
core
key
membran
fusion
structur
upon
bind
bind
form
temporari
intermedi
structur
caus
viral
cell
membran
move
close
proxim
fuse
membran
protein
play
key
role
cov
tropism
morbid
proteolysi
mani
kind
proteas
review
ref
host
digest
protein
merscov
exampl
furin
use
two
step
merscov
activ
process
cleavag
infect
first
furin
recogn
posit
cleav
protein
biosynthesi
next
digest
posit
adjac
fusion
peptid
viral
entri
tabl
structur
protein
gene
potenti
function
merscov
code
gene
function
andor
effect
cellular
respons
host
envelop
e
protein
inner
membran
protein
also
small
structur
protein
merscov
amino
acid
length
predict
contain
least
one
transmembran
helix
e
protein
cov
play
import
role
intracellular
traffick
host
recognit
viral
assembl
viru
bud
howev
exact
function
cov
e
protein
infect
remain
unclear
research
use
infecti
bronchiti
viru
ibv
infect
prove
e
protein
requir
virion
assembl
role
disturb
secretori
pathway
merscov
e
protein
singl
hydrophob
domain
hd
target
golgi
composit
membran
cation
channel
activ
vitro
purifi
merscov
e
protein
form
pentamer
ion
channel
lipid
bilay
lack
e
protein
may
lead
elimin
channel
activ
base
propos
channel
activ
virul
factor
merscov
e
protein
potenti
antivir
therapeut
target
research
use
softwar
program
lasergen
dnastar
inc
usa
phyre
structur
bioinformat
group
imperi
colleg
london
uk
pymol
llc
usa
identifi
potenti
b
epitop
high
antigen
posit
e
protein
membran
protein
import
viral
assembl
format
viral
envelop
format
viral
core
interact
nucleocapsid
n
protein
therefor
develop
fusion
peptid
ifn
antagonist
may
import
treatment
option
n
protein
merscov
phosphoryl
basic
protein
second
largest
structur
protein
contain
amino
acid
residu
n
protein
bind
rna
genom
form
nucleocapsid
import
viru
replic
assembl
nterminu
n
protein
residu
may
rnabind
region
cterminu
may
selfbind
oligomerform
region
comparison
homolog
merscov
cov
show
although
n
protein
low
homolog
entir
amino
acid
sequenc
certain
local
amino
acid
sequencesespeci
ntermin
amino
acid
sequencear
highli
conserv
sarscov
n
protein
increas
replic
overexpress
nucleocapsid
structur
requir
recognit
characterist
sequenc
viral
rna
also
must
recogn
bind
structur
viral
protein
n
protein
form
complex
viral
genom
rna
rna
protect
destruct
nucleas
host
cell
xray
diffract
measur
high
resolut
use
discov
intrins
disord
region
idr
ntd
nterminu
n
protein
model
show
ntd
cov
rel
conserv
n
protein
sarscov
merscov
adpribosyl
common
posttransl
modif
howev
unclear
regul
rna
viru
infect
studi
screen
adpribosyl
protein
infect
cov
research
identifi
adpribosyl
protein
kda
vivo
subsequ
verifi
cov
n
protein
therefor
cov
n
protein
may
modul
posttransl
modif
certain
import
protein
n
protein
cov
may
inhibit
type
ifn
product
interf
interact
tripl
motif
protein
retino
acidinduc
gene
rigi
bind
ubiquitin
ligas
thu
inhibit
ubiquitin
activ
rigi
mediat
ultim
lead
inhibit
ifn
product
suggest
n
protein
cov
regul
host
immun
respons
viru
merscov
n
protein
thought
interact
mannoseassoci
serin
proteas
translat
elong
factor
host
mannosebind
lectin
recogn
mannan
surfac
virusinfect
cell
recruit
activ
enzymat
activ
eventu
caus
local
system
inflammatori
respons
act
translat
elong
factor
catalyz
aminoacyltrna
site
ribosom
play
regulatori
role
assembl
cytoskeleton
microfila
cytokinesi
ring
interact
merscov
n
protein
disrupt
format
cytokinesi
loop
inhibit
lymphocyt
prolifer
may
explain
reduct
number
lymphocyt
patient
mer
merscov
larg
number
genom
encod
varieti
ap
dorf
even
among
close
relat
cov
number
sequenc
differ
lead
host
shift
hcov
emerg
merscov
ap
orf
import
replic
viru
vivo
vitro
allow
orf
use
target
vaccin
product
emphas
merscov
ap
potenti
target
monitor
therapeut
treatment
addit
parallel
disrupt
ap
orf
provid
rapid
respons
platform
new
mutat
sar
merscov
ap
orf
ap
merscov
may
invok
hostil
respons
differ
mode
includ
ifn
antagon
protein
kinas
r
pkr
nuclear
factor
kappa
b
nfjb
pathway
attenu
function
mutant
mainli
caus
hostrespons
disord
includ
disrupt
cellular
process
strong
inflamm
protein
increas
ifn
pathway
activ
potent
ifn
antagonist
inhibit
ifn
product
eg
interferon
stimul
respons
element
isr
signal
pathway
merscov
protein
like
interfer
antiantivir
effect
ifn
ifn
antagon
key
element
viral
pathogenesi
ifninduc
oligoadenyl
synthas
oa
rnase
l
pathway
activ
sens
viral
doublestrand
rna
dsrna
thu
viru
singlestrand
rna
ssrna
host
cleav
hinder
replic
spread
viru
mainli
locat
nucleu
protein
locat
cytoplasm
phosphodiesteras
pde
activ
activ
rnase
l
treatment
interfer
pathogenesi
merscov
vivo
model
merscov
essenti
pkr
antagonist
activ
establish
infect
spread
merscov
must
regul
complex
antivir
hostrespons
network
type
ifn
ifnab
respons
phosphoryl
pkr
lead
inhibit
translat
cell
virus
format
stress
granul
sg
provid
platform
antivir
signal
pathway
merscov
need
prevent
strong
hostdepend
reaction
infect
viral
infect
act
interfer
nfjbmediat
innat
immun
respons
bind
nfjb
nuclear
transcript
transloc
nucleu
play
competit
role
also
effect
regul
nfjbmediat
inflamm
terminu
cov
genom
encod
polyprotein
polyprotein
may
cleav
nonstructur
protein
nsp
protein
essenti
viral
replic
transcript
merscov
proteas
papainlik
proteas
plpro
affect
differ
genet
evolutionari
effect
protein
sequenc
format
codon
usag
pattern
codon
usag
bia
cleavag
point
plpro
posit
produc
three
nsp
cleavag
occur
remain
posit
kda
multifunct
protein
contain
differ
domain
region
associ
viral
rna
nucleocapsid
protein
viral
protein
involv
polyprotein
process
plpro
activ
establish
target
new
antivir
drug
plpro
control
wide
rang
compon
mutat
effect
antivir
drug
plpro
inhibitor
inhibitor
tabl
studi
innat
immunosuppress
profil
wide
involv
virusencod
polyprotein
ppla
pplab
nsp
process
therefor
essenti
indispens
viru
surviv
addit
lack
cell
homolog
human
make
ideal
target
antivir
drug
design
adapt
evolut
merscov
strain
ongo
cov
use
primari
screen
target
sequenc
consid
monitor
sitespecif
investig
cov
rna
synthesi
associ
replic
organel
ro
compos
modifi
endoplasm
reticulum
er
membran
convert
doublemembran
vesicl
dmv
contain
viral
dsrna
convert
crimp
membran
togeth
form
reticulovesicular
network
sarscov
contain
transmembran
domain
respons
format
dmv
addit
cisact
element
end
code
region
facilit
specif
recognit
viral
rna
necessari
effici
viru
replic
merscov
helicas
one
import
viral
replic
enzym
profoundli
affect
tropism
virul
unfold
dna
rna
direct
kinemat
protein
catalyz
progress
separ
doublestrand
nucleic
acid
two
singlestrand
nucleic
acid
use
energi
gener
atp
hydrolysi
therefor
helicas
use
therapeut
target
inhibit
replic
merscov
addit
major
activ
viral
replic
rnadepend
rna
polymeras
rdrp
play
role
viru
replic
transcript
use
diagnost
rdrpseq
assay
antivir
target
polymeras
inhibitor
exoribonucleas
activ
endoribonucleas
activ
effect
prevent
activ
dsrna
sensor
includ
melanoma
differentiationrel
protein
oa
pkr
host
cell
sadenosinelmethionin
sam
depend
omethyltransferas
omtas
play
import
role
regul
omtas
activ
sam
bind
promot
assembl
complex
enzymat
convert
om
rna
samdepend
manner
oh
methyl
sam
alanin
mutagenesi
use
identifi
residu
affect
rna
recognit
balanc
samsadenosyllhomocystein
sah
regul
omethyltransferas
activ
increas
sah
hydrolas
inhibit
interfer
cov
replic
cycl
work
togeth
exert
effect
pair
membran
promot
membran
prolifer
form
perinuclear
vesicl
thought
requir
fulllength
dmv
seen
cell
coexpress
ctermin
truncat
adapt
event
occur
inhibit
ifn
respons
via
deubiquitin
deesterif
activ
current
undergo
select
base
merscov
isol
human
camel
posit
select
chang
observ
humanonli
virus
suggest
viru
adapt
human
repres
potenti
select
pressur
help
viru
escap
cellular
innat
immun
use
ifninduc
protein
tetratricopeptid
repeat
protein
inhibit
viral
translat
use
revers
genet
merscov
show
attenu
base
type
ifn
mutat
partial
recov
absenc
plpro
ubiquitinlik
domain
ubl
becom
fulli
flexibl
bind
ubiquitin
increas
flexibl
import
interact
downstream
protein
inhibit
innat
immun
four
major
residu
involv
conserv
merscov
differ
betacoronavirus
thu
downregul
deubiquitin
may
lead
weaken
interact
merscov
host
immun
system
inhibit
host
innat
immun
respons
bind
dsrna
cell
doublestrand
dna
therefor
consid
best
checkpoint
viral
invas
time
cterminu
target
tnf
receptorassoci
factor
inhibit
product
ifnb
addit
activ
interferonregul
transcript
factor
pkr
inhibit
domain
cov
may
also
interact
cyclophilin
consid
major
virul
factor
degrad
host
mrna
mrna
degrad
activ
merscov
separ
translat
inhibitori
function
furthermor
certain
residu
merscov
crucial
evad
translat
shutdown
escap
merscov
mrna
inhibit
merscov
promot
cytoplasm
origin
complet
effect
treatment
merscov
current
treatment
method
mainli
imit
treatment
sarscov
compris
follow
symptomat
treatment
includ
biolog
therapi
monoclon
antibodi
mab
blocker
proteas
inhibitor
corticosteroid
ifn
chemic
drug
acyclovir
chlorpromazin
hydrochlorid
loperamid
lopinavir
broadspectrum
antibiot
ribavirin
lopinavirritonavir
mycophenol
mofetil
nanoparticl
vaccin
howev
wellorgan
clinic
trial
yet
carri
therefor
analyz
potenti
prevent
treatment
method
perspect
molecular
characterist
provid
refer
develop
effect
target
prevent
treatment
especi
biolog
strategi
mab
regard
potenti
intervent
method
use
diagnos
mani
diseas
main
product
shown
tabl
antibodi
isol
recov
mer
patient
preclin
develop
product
complet
good
manufactur
practic
gmp
approv
cell
line
express
high
concentr
purifi
highli
effici
antibodi
establish
studi
human
nab
mab
perform
antibodybas
drug
specif
effect
inhibitor
rbd
tabl
summari
potenti
product
target
merscov
protein
vivoin
vitro
safetyadvantag
mersmab
rbd
vitro
rbd
vitroin
vivo
mous
rbd
vitro
rbd
vitroin
vivo
mous
prophylact
therapeut
rbd
vitroin
vivo
mous
rbd
vitroin
vivo
mous
target
ntd
rbd
stabl
chines
hamster
ovari
cho
cell
line
prophylact
therapeut
rbd
vitroin
vivo
rhesu
monkey
prophylact
vitro
rbd
vitro
rbd
vitro
rbd
igg
fusion
rbdigg
fusion
potenti
mersspecif
agent
plpro
inhibitor
vitro
vitroin
vivo
marmoset
high
activ
low
micromolar
rang
vitro
better
outcom
reduc
mortal
marmoset
show
strong
resist
merscovneutr
activ
tabl
describ
studi
potenti
antibodi
mab
potenti
antibodi
demonstr
effect
prophylaxi
merscovinfect
anim
model
follow
treatment
mersmab
rbd
igg
fusion
recogn
variabl
glycosyl
loop
cov
defin
four
conform
state
trimer
studi
may
contribut
understand
fusion
initi
provid
basi
design
structurebas
cov
vaccin
merscov
sp
essenti
viru
enter
cell
therefor
therapeut
agent
blockad
viral
cell
membran
fusion
exploit
felin
protein
inhibitor
inhibitor
plpro
inhibitor
furin
inhibitor
kinas
inhibitor
ifninduc
transmembran
ifitm
protein
posit
posit
identifi
lu
et
al
liu
et
al
respons
format
fusion
core
peptid
inhibit
viral
replic
merscov
cell
line
hfl
play
role
inhibit
replic
merscov
stimulatori
fusion
although
littl
knowledg
concern
assembl
releas
inhibit
viral
process
may
import
goal
futur
lowtemperatur
electron
microscopi
recent
reveal
global
prefusion
structur
fulllength
sexodomain
indic
ntd
c
termin
domain
ctd
form
v
shape
help
overal
trimer
triangular
appear
subunit
link
viral
membran
character
presenc
long
alpha
helix
structur
inform
could
form
basi
structurebas
immunogen
design
vaccin
betacoronavirus
combin
comput
biolog
virolog
could
acceler
advanc
design
agent
act
merscov
result
higher
efficaci
n
protein
merscov
abundantli
produc
infect
show
strong
immunogen
indic
ideal
antigen
viru
antibodi
detect
antin
igg
use
indic
suscept
human
cov
infect
report
describ
new
method
gener
mab
direct
n
protein
use
wheat
germ
cell
protein
synthesi
system
larg
number
merscov
n
protein
antigen
success
prepar
highli
solubl
intact
immun
state
given
biolog
characterist
merscov
infect
prevent
control
measur
critic
prevent
possibl
spread
viru
patient
mer
effect
earli
diagnosi
earli
treatment
difficult
achiev
mainli
atyp
earli
symptom
limit
detect
method
airborn
transmiss
therefor
regardless
diagnosi
healthcar
provid
alway
take
consist
standard
precaut
patient
igmtyp
antibodi
merscov
protein
need
detect
effect
necessit
develop
effect
antibodi
explos
epidem
merscov
pose
seriou
threat
global
public
health
emphas
need
investig
epidemiolog
pathogenesi
viru
addit
develop
effect
therapeut
prevent
drug
merscov
infect
despit
rapid
advanc
diagnost
public
health
measur
new
merscov
case
still
report
suggest
multipl
intervent
target
differ
affect
popul
may
necessari
stop
outbreak
describ
herein
structur
inform
associ
merscov
protein
may
use
develop
differ
potenti
intervent
limit
outbreak
merscov
need
better
understand
pathogenesi
merscov
order
identifi
viral
host
factor
play
import
role
develop
mer
human
may
provid
potenti
novel
therapeut
intervent
option
